Aehr Test Systems - AEHR Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aehr Test Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AEHR shares.
View AEHR analyst ratings or view top-rated stocks.

1 equities research analysts have issued 1 year price targets for Aehr Test Systems' shares. Their AEHR share price forecasts range from $31.00 to $31.00. On average, they predict the company's share price to reach $31.00 in the next year. This suggests a possible upside of 109.5% from the stock's current price.
View analysts price targets for AEHR or view top-rated stocks among Wall Street analysts.

Aehr Test Systems' stock was trading at $24.18 at the beginning of the year. Since then, AEHR shares have decreased by 38.8% and is now trading at $14.80.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 6th 2022.
View our AEHR earnings forecast.

Aehr Test Systems will be holding an earnings conference call on Thursday, October 6th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "8724719".

Aehr Test Systems (NASDAQ:AEHR) issued its quarterly earnings data on Tuesday, July, 19th. The semiconductor company reported $0.20 EPS for the quarter. The semiconductor company earned $20.29 million during the quarter. Aehr Test Systems had a net margin of 18.59% and a trailing twelve-month return on equity of 23.35%.

Aehr Test Systems updated its FY 2023 earnings guidance on Tuesday, August, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $60.00 million-$70.00 million, compared to the consensus revenue estimate of $70.78 million.

1 employees have rated Aehr Test Systems Chief Executive Officer Rhea J. Posedel on Glassdoor.com. Rhea J. Posedel has an approval rating of 100% among the company's employees. This puts Rhea J. Posedel in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aehr Test Systems investors own include Arbutus Biopharma (ABUS), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO), Palatin Technologies (PTN), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Vaxart (VXRT), Aclaris Therapeutics (ACRS) and Acasti Pharma (ACST).

Aehr Test Systems trades on the NASDAQ under the ticker symbol "AEHR."

Shares of AEHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEHR stock can currently be purchased for approximately $14.80.

Aehr Test Systems (NASDAQ:AEHR) has a market capitalization of $405.43 million and generates $50.83 million in revenue each year. The semiconductor company earns $9.45 million in net income (profit) each year or $0.34 on an earnings per share basis.

Aehr Test Systems' mailing address is 400 KATO TERRACE, FREMONT CA, 94539. The official website for the company is www.aehr.com. The semiconductor company can be reached via phone at (510) 623-9400, via email at aehr@mkr-group.com, or via fax at 510-623-9450.